title: Teenagers as a moving target: how can teenagers be encouraged to accept treatment?
abstract: Pediatric patients exhibit their own needs and problems and are now considered as a real patient group in which downsizing the adult formulation is not the best choice and may result in problems. Adolescence (between 12 and 18 years) is a transitional period of life from puberty to adulthood and, in this pediatric subgroup population, complex problems are observed in compliance with chronic treatments. Heterogeneity exists in this group which follows very different and sometimes short trends and tendencies and where illness can be a problem leading to stigmatization. Influence of social environment as well as friends is complex in this period of life. Teenagers have to take care of themselves and be part of the treatment including all the features of the social code of this group. Particular attention has to be paid to formulation and packaging in order to increase compliance and to suit the specific needs of this pediatric subgroup. Some examples are given for different drug forms.
authors.affiliation: Biopharmaceutical Department, UFR Pharmacie, University d'Auvergne, 28, Place H. Dunant, B.P. 38, F-63001 Clermont-Ferrand, France. pascale.gauthier@udamail.fr.
authors.forename: Pascale
authors.initials: P
authors.lastname: Gauthier
authors.affiliation: Biopharmaceutical Department, UFR Pharmacie, University d'Auvergne, 28, Place H. Dunant, B.P. 38, F-63001 Clermont-Ferrand, France. j-michel.cardot@udamail.fr.
authors.forename: Jean-Michel
authors.initials: JM
authors.lastname: Cardot